Giwercman A, von der Maase H, Rørth M, Skakkebaek N E
University Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark.
World J Urol. 1994;12(3):125-30. doi: 10.1007/BF00192268.
During a recent international workshop on carcinoma in situ and cancer of the testis held in November 1992, there was consensus about the management of the contralateral testis in patients with unilateral testicular cancer [20]. Such men should be offered a biopsy of the contralateral testis. This consensus was based on (1) the high prevalence of carcinoma in situ (CIS) in the contralateral testis found not only in Danish men but also in studies from other countries and (2) the possibility of eradicating the CIS and thereby preventing the development of invasive cancer by means of localized irradiation with preservation of testosterone production in the testis. The aim of this paper is to outline the present status of the radiation treatment of CIS of the testis.
在1992年11月举行的一次关于原位癌和睾丸癌的国际研讨会上,对于单侧睾丸癌患者对侧睾丸的处理达成了共识[20]。这类男性患者应接受对侧睾丸活检。这一共识基于以下两点:(1)不仅在丹麦男性中,而且在其他国家的研究中都发现对侧睾丸原位癌(CIS)的高发病率;(2)通过局部照射根除原位癌并由此预防浸润性癌发展的可能性,同时保留睾丸的睾酮分泌功能。本文的目的是概述睾丸原位癌放射治疗的现状。